Home/Filings/4/0001209191-23-030736
4//SEC Filing

Burkhart Erin 4

Accession 0001209191-23-030736

CIK 0001048477other

Filed

May 17, 8:00 PM ET

Accepted

May 18, 5:31 PM ET

Size

4.5 KB

Accession

0001209191-23-030736

Insider Transaction Report

Form 4
Period: 2023-05-16
Burkhart Erin
GVP, Chief Accounting Officer
Transactions
  • Tax Payment

    Common Stock

    2023-05-16$92.02/sh796$73,24814,094 total

Issuer

BIOMARIN PHARMACEUTICAL INC

CIK 0001048477

Entity typeother

Related Parties

1
  • filerCIK 0001927648

Filing Metadata

Form type
4
Filed
May 17, 8:00 PM ET
Accepted
May 18, 5:31 PM ET
Size
4.5 KB